, category News

Unique Czech technology brings revolutionary treatment for atrial fibrillation

Cardiologists at the Na Homolce Hospital have successfully used a new Czech technology in a clinical trial for the first patients with atrial fibrillation, which is changing the standards of treatment. It will offer patients with the most common cardiac arrhythmia faster, gentler and safer catheterisation procedures

This method brings a number of benefits to patients:

  • The procedure is 40-70% shorter than traditional methods thanks to the combination of pulsed technology and a catheter that is unique in its design.
  • It minimizes the risk of damage to surrounding tissues, which increases the safety and gentleness of the procedure.
  • Single-shot pulmonary vein isolation (PVI): simply and effectively isolates the pulmonary vein, the main trigger of atrial fibrillation, reducing the length of the procedure by 40-70%.
  • Versatility and ease of use: the physician can change the shape of the catheter as needed, allowing him to adapt the treatment to the anatomy of each patient's heart, which also opens up the possibility for other therapeutic applications. 

The first patients received the new system as part of a clinical trial led by Prof. Petr Neužil, MD, FESC, Chief of the Cardiology Department at the Na Homolce Hospital in the Czech Republic. "I am proud to have the first Czech technology that we can use for interventional procedures for a long time. In the first six patients we treated with the Easy Pulse catheter at the Hospital na Homolce together with my colleague Prof. Vivek Reddy, the procedure proved to be safe, effective and simple. The first results indicate that this will be a technology that has great potential to facilitate and improve the treatment of our patients, says Prof. Neužil."

Three key names are behind the development of the catheter: prof. Petr Neužil, prof. MUDr. Štěpán Havránek, Ph.D. from the 1st Faculty of Medicine of Charles University in Prague and MUDr. Pavel Hála from the Institute of Physiology of the 1st Faculty of Medicine of Charles University, who have performed the largest number of tests on biomodels in the joint experimental laboratory of the 1st Faculty of Medicine of Charles University between 2020 and 2024. The laboratory of the Institute of Physiology of the 1st Faculty of Medicine of Charles University under the leadership of doc. MUDr. Mikuláš Mlček, Ph.D. provided complete facilities for the four-year research.